Drug Approval Package
-
Trileptal (Oxcarbazepine) Oral Suspension
Company: Novartis Pharmaceuticals Corporation
Application No.: 21-285
Approval Date: 5/29/01
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Chemistry Review(s) (PDF)
-
Pharmacology Review(s) (PDF)
-
Statistical Review(s) (PDF)
-
Microbiology Review(s) (PDF)
Date created: April 04, 2002
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-